Edwards Life Sciences Corp. (EW): Today's Featured Health Care Laggard

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Edwards Life ( EW) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole was unchanged today. By the end of trading, Edwards Life fell $3.56 (-5.4%) to $62.73 on heavy volume. Throughout the day, 5,912,744 shares of Edwards Life exchanged hands as compared to its average daily volume of 1,499,200 shares. The stock ranged in price between $61.91-$64.33 after having opened the day at $62.57 as compared to the previous trading day's close of $66.29. Other companies within the Health Care sector that declined today were: Mast Therapeutics ( MSTX), down 42.4%, Curis ( CRIS), down 18.7%, Array BioPharma ( ARRY), down 12.5% and Alliance HealthCare Services ( AIQ), down 12.2%.

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. Edwards Life has a market cap of $7.1 billion and is part of the health services industry. The company has a P/E ratio of 18.5, above the S&P 500 P/E ratio of 17.7. Shares are down 27.7% year to date as of the close of trading on Friday. Currently there are 7 analysts that rate Edwards Life a buy, 1 analyst rates it a sell, and 7 rate it a hold.

TheStreet Ratings rates Edwards Life as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. However, as a counter to these strengths, we find that the stock has had a generally disappointing performance in the past year.

On the positive front, Hemispherx Biopharma ( HEB), up 60.0%, Given Imaging ( GIVN), up 27.1%, Prana Biotechnology ( PRAN), up 16.5% and Atossa Genetics ( ATOS), up 14.7% , were all gainers within the health care sector with Teva Pharmaceutical Industries ( TEVA) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists